MedTrace Logo

Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome

NCT05561270 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-05-06

No results posted yet for this study

Summary

Chronic pain is a major complaint among many individuals living with hypermobile Ehlers Danlos Syndrome (hEDS) and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. This investigation will examine the impacts of green light exposure on subject-reported pain severity and symptoms. Knowing whether this intervention can improve pain and quality of life in this population may offer valuable guidance to clinicians who treat hEDS patients and to hEDS patients themselves.

Conditions

  • Ehlers-Danlos Syndrome
  • Pain, Chronic

Interventions

DEVICE

White LED light

Exposure to white LED light for 1-2 hours/day x 10 weeks

DEVICE

Green LED light

Exposure to green LED light for 1-2 hours/day x 10 weeks

Sponsors & Collaborators

  • New York Institute of Technology

    lead OTHER

Principal Investigators

  • Philip Noto, DO · NYITCOM

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-21
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05561270 on ClinicalTrials.gov